Cargando…
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
Current T cell engineering approaches redirect patient T cells to tumors by transducing antigen–specific T cell receptors (TCRs) or chimeric antigen receptors (CARs) that target a single antigen.(1–3) However, few tumor-specific antigens have been identified, and healthy tissues that express the tar...
Autores principales: | Kloss, Christopher C, Condomines, Maud, Cartellieri, Marc, Bachmann, Michael, Sadelain, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505184/ https://www.ncbi.nlm.nih.gov/pubmed/23242161 http://dx.doi.org/10.1038/nbt.2459 |
Ejemplares similares
-
Tumor-Targeted Human T Cells Expressing CD28-Based Chimeric Antigen Receptors Circumvent CTLA-4 Inhibition
por: Condomines, Maud, et al.
Publicado: (2015) -
Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
por: Cartellieri, Marc, et al.
Publicado: (2010) -
Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function
por: Salzer, Benjamin, et al.
Publicado: (2020) -
Programming CAR T Cell Tumor Recognition: Tuned Antigen Sensing and Logic Gating
por: Hamieh, Mohamad, et al.
Publicado: (2023) -
HIV Eradication: Combinatorial Approaches to Activate Latent Viruses
por: De Crignis, Elisa, et al.
Publicado: (2014)